Evidence map›Paper›PMID 26173802›Full record

ReviewPediatric blood & cancer2015

Diagnostic and therapeutic challenges in a child with complete interferon-γ receptor 1 deficiency.

Peter Olbrich, Maria Teresa Martínez-Saavedra, José Maria Perez-Hurtado, Cristina Sanchez, Berta Sanchez, Caroline Deswarte, Ignacio Obando, Jean-Laurent Casanova, Carsten Speckmann, Jacinta Bustamante and 2 more

Erratum issuedOpen access · greenAbstract readCase ReportsReview
In one paragraph

Review in Pediatric blood & cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. DisseminatedJournal of pediatric genetics · 2020
    Article
  8. Review
  9. Review
  10. B Regulatory Cells: Players in Pregnancy and Early Life.International journal of molecular sciences · 2018
    Review
  11. Review
  12. Article
  13. Frequency ofTurk pediatri arsivi · 2017
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 5 countries.

Peter OlbrichPediatric Infectious Diseases and Immunopathology Unit, Hospital Virgen del Rocio, Instituto de Biomedicina de Sevilla, Sevilla, Spain.
Maria Teresa Martínez-SaavedraDepartment of Immunology, Gran Canaria Dr. Negrín University Hospital, Las Palmas de Gran Canaria, Spain.
José Maria Perez-HurtadoPediatric Hematology Unit, Hospital Virgen del Rocio, Sevilla, Spain.
Cristina SanchezPediatric Infectious Diseases and Immunopathology Unit, Hospital Virgen del Rocio, Instituto de Biomedicina de Sevilla, Sevilla, Spain.
Berta SanchezDepartment of Immunology, Hospital Virgen del Rocio, Sevilla, Spain.
Caroline DeswarteLaboratory of Human Genetics of Infectious Diseases, Necker Branch, Necker Hospital for Sick Children, Paris, France.
Ignacio ObandoPediatric Infectious Diseases and Immunopathology Unit, Hospital Virgen del Rocio, Instituto de Biomedicina de Sevilla, Sevilla, Spain.
Jean-Laurent CasanovaLaboratory of Human Genetics of Infectious Diseases, Necker Branch, Necker Hospital for Sick Children, Paris, France.
Carsten SpeckmannDepartment of Pediatrics and Adolescent Medicine, University Medical Center, Freiburg, Germany.
Jacinta BustamanteLaboratory of Human Genetics of Infectious Diseases, Necker Branch, Necker Hospital for Sick Children, Paris, France.
Carlos Rodriguez-GallegoDepartment of Immunology, Gran Canaria Dr. Negrín University Hospital, Las Palmas de Gran Canaria, Spain.
Olaf NethPediatric Infectious Diseases and Immunopathology Unit, Hospital Virgen del Rocio, Instituto de Biomedicina de Sevilla, Sevilla, Spain.
Hospital Universitario Virgen del Rocío · ESHospital Universitario de Gran Canaria Doctor Negrín · ESHuman Genetic of Infectious Diseases · FRInstituto de Biomedicina de Sevilla · ESUniversité Paris Cité · FRUniversity of Freiburg · DE

Funding

Transforming Translational Science and Education to Benefit Human HealthUL1TR000043 · NCATS · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY · 2012 to 2015
$26.8M
A genetic dissection of Mendelian susceptibility to mycobacterial diseases (MSMD)R01AI089970 · NIAID · ROCKEFELLER UNIVERSITY · PI CASANOVA, JEAN-LAURENT · 2010 to 2014
$2.5M
NCATS NIH HHS 8UL1TR000043NCATS NIH HHS UL1 TR000043NIAID NIH HHS 5R01AI089970NIAID NIH HHS R01 AI089970
6 · The paper itself

Abstract

Autosomal recessive (AR) complete Interferon-γ Receptor1 (IFN-γR1) deficiency is a rare variant of Mendelian susceptibility to mycobacterial disease (MSMD). Although hematopoietic stem cell transplantation (HSCT) remains the only curative treatment, outcomes are heterogeneous; delayed engraftment and/or graft rejection being commonly observed. This case report and literature review expands the knowledge about this rare but potentially fatal pathology, providing details regarding diagnosis, antimicrobial treatment, transplant performance, and outcome that may help to guide physicians caring for patients with AR complete IFN-γR1 or IFN-γR2 deficiency.

Indexed as

Stem Cell TransplantationAllograftsAnti-Infective AgentsChild, PreschoolGenetic Diseases, InbornHumansInterferon gamma ReceptorMaleReceptors, InterferonAnti-Infective AgentsInterferon gamma ReceptorReceptors, Interferonatypical mycobacteriainfantinterferon gamma receptorprimary immunodeficiencytransplantation

Identifiers

PMID26173802
PMCPMC4651008
OpenAlexW2170762856

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.